SKK
BLUE

Shepherd Kaplan Krochuk’s bluebird bio BLUE Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-760
Closed -$224K – 571
2014
Q1 		$224K Buy
+760
New +$230K 0.03% 425

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Shepherd Kaplan Krochuk's BLUE Position: Q2 2014 in Review

Shepherd Kaplan Krochuk sold out of bluebird bio (BLUE) in Q2 2014, closing a stake of 760 shares — an estimated $224K sold.

Shepherd Kaplan Krochuk first reported a position in BLUE in Q1 2014 and held it in 1 quarter. The position peaked at $224K in Q1 2014. 104 funds tracked by Wall St. Rank hold BLUE as of Q2 2014.

  • Shepherd Kaplan Krochuk reported no remaining bluebird bio position as of Q2 2014 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 760 bluebird bio shares in Q2 2014, an estimated $224K.
  • Shepherd Kaplan Krochuk first reported a position in bluebird bio in Q1 2014 and held it in 1 quarter.
  • Shepherd Kaplan Krochuk's bluebird bio position peaked at $224K in Q1 2014.
  • 104 funds tracked by Wall St. Rank held bluebird bio as of Q2 2014.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2014, filed 14 Aug 2014.